lunes, 1 de enero de 2024

Recommendations for management of positive monosomy X on cell-free DNA screening

https://innovationdistrict.childrensnational.org/recommendations-for-management-of-positive-monosomy-x-on-cfdna-screening/

First-of-its-kind holistic program for managing pain in sickle cell disease

https://innovationdistrict.childrensnational.org/first-of-its-kind-holistic-program-for-managing-pain-in-sickle-cell-disease/

Why a colorectal transition program matters

https://innovationdistrict.childrensnational.org/why-a-colorectal-transition-program-matters/

AAP names Children’s National gun violence study one of the most influential articles ever published

https://innovationdistrict.childrensnational.org/aap-names-gun-violence-study-one-of-the-most-influential-articles-ever-published/

First infants in the U.S. with specially modified pacemakers show excellent early outcomes

https://innovationdistrict.childrensnational.org/first-infants-in-the-u-s-with-specially-modified-pacemakers-show-excellent-early-outcomes/

New model to treat Becker Muscular Dystrophy

https://innovationdistrict.childrensnational.org/new-model-to-treat-becker-muscular-dystrophy/

Children’s National gives first commercial dose of new FDA-approved gene therapy for Duchenne muscular dystrophy

https://innovationdistrict.childrensnational.org/childrens-national-gives-first-dose-of-new-dmd-drug/